참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Sodium Azide | HCID 33557 | — |
| 반응물 | Rifamycin S | HCID 6436726 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 용매 | N-Methylformamide | HCID 31254 | — |
| 생성물 | 3-Aminorifamycin S | HCID 12889622 | — |
반응 단계
3-amino-4-deoxo-4-imino-rifamycin S, (a) above, is described in U.S. Pat. No. 4,017,481, where it is made by reacting 3-amino-rifamycin S with gaseous ammonia. The reaction is carried out in a solution of tetrahydrofuran at room temperature for 15 hours with further addition of ammonia. The starting material, 3-amino-rifamycin S may obtained as described in U.S. Pat. No. 4,007,169, where it is obtained by reacting sodium azide with rifamycin S. The reaction is carried out in methylformamide at 35° C. for 60 minutes. The reaction mixture is diluted with methylene chloride and washed with water. The aqueous phase contains rifamycin SV which may be oxidized by, for example, nitrous acid to the starting material rifamycin S. The organic phase is washed with water, dried with sodium sulphate and evaporated to yield 3-amino rifamycin S which is recrystallized from 2-methoxy ethanol.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04743619 |
|---|
| 출처 데이터셋 | uspto-grants-1988_05 |
|---|
| ORD ID | ord-603eb44945514faf8a96f031da6b9678 |
|---|
| 출처 메모 | uspto-grants-1988_05 |
|---|